Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Urea and sulfamide derivatives as inhibitors of TAFIa

Urea and sulfamide derivatives as inhibitors of TAFIa

US Patent 8389764 · Granted Mar 5, 2013

Estimated economic value: $25,584,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2025
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Substituted S-alaninate derivatives2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022
Targeted cytotoxic ratjadone derivatives and conjugates thereof2022
Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2021
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020
Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic ac2020
Exendin-4 derivatives as dual GLP1/glucagon agonists2020